Answer
The selected product treats mild to moderate type 1 Gaucher disease in adults when enzyme replacement therapy is unsuitable, and progressive neurological manifestations of Niemann–Pick type C disease in adults and children.
Sources for this answer
- Yargesa (miglustat) 100mg Hard Capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.